Latest data from October 8, 2021
Number of Health Center respondents = 14 (52% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 6,321 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 71.71% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 407 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 66.86% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 24.82% | 28.75% |
| White, Hispanic/Latino Patients | 0.82% | 0.98% |
| Black/African American, Non-Hispanic/Latino Patients | 0.49% | 1.97% |
| Black/African American, Hispanic/Latino Patients | 0.06% | 0.00% |
| Asian Patients3 | 2.18% | 3.19% |
| American Indian/Alaska Native Patients3 | 57.03% | 44.72% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.60% | 4.67% |
| Patients with More than one race3 | 1.41% | 1.72% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.32% | 0.74% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.09% | 1.72% |
| Unreported/Refused to Report Race and Ethnicity | 11.17% | 11.55% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 206 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 48.61% |
| COVID-19 Immunization Series Completed | 284 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 37.19% |
| COVID-19 Immunization Series Additional | 666 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 77.08% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 35.92% | 44.01% | 19.07% |
| White, Hispanic/Latino Patients | 1.94% | 0.70% | 2.55% |
| Black/African American, Non-Hispanic/Latino Patients | 6.80% | 0.35% | 0.00% |
| Black/African American, Hispanic/Latino Patients | 0.49% | 0.00% | 0.00% |
| Asian Patients3 | 10.19% | 4.93% | 0.75% |
| American Indian/Alaska Native Patients3 | 12.62% | 16.90% | 58.41% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.49% | 0.00% | 0.00% |
| Patients with More than one race3 | 0.00% | 1.06% | 2.25% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.46% | 2.11% | 0.15% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.40% | 1.41% | 1.35% |
| Unreported/Refused to Report Race and Ethnicity | 26.70% | 28.52% | 15.47% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 35.71% |
| 1 to 24 Hours | 35.71% |
| More Than 24 Hours | 28.57% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 7.14% |
| Staffing to administer the vaccine | 50.00% |
| Vaccine confidence | 35.71% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 7.14% |
| Other | 0.00% |
| None | 35.71% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 0.00% |
| Average Percent of Health Center Visits Conducted Virtually | 15.36% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 14.29% |
| Number of Mobile Van Sites | 2 |
| Number of Pop-up Clinics | 15 |
| Number of School-Based Vaccination Sites | 9 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 50.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 35.71% |
| None | 21.43% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 7.14% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 14.29% |
| Therapy administration/onsite logistics | 0.00% |
| Other | 7.14% |
| None | 78.57% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
